The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines
- PMID: 19351832
- PMCID: PMC2703812
- DOI: 10.1158/0008-5472.CAN-08-4112
The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines
Abstract
Androgen-dependent prostate cancer typically progresses to castration-resistant prostate cancer (CRPC) after the androgen deprivation therapy. MicroRNAs (miR) are noncoding small RNAs (19-25nt) that play an important role in the regulation of gene expression. Recent studies have shown that miR expression patterns are significantly different in normal and neoplastic prostate epithelial cells. However, the importance of miRs in the development of CRPC has not yet been explored. By performing genome-wide expression profiling of miRs, we found that expression levels of several miRs, in particular miR-221 and miR-222, were significantly increased in CRPC cells (the LNCaP-derived cell line LNCaP-Abl), compared with those in the androgen-dependent prostate cancer cell line (LNCaP). Overexpression of miR-221 or miR-222 in LNCaP or another androgen-dependent cell line, LAPC-4, significantly reduced the level of the dihydrotestosterone (DHT) induced up-regulation of prostate-specific antigen (PSA) expression and increased androgen-independent growth of LNCaP cells. Knocking down the expression level of miR-221 and miR-222 with antagonist miRs in the LNCaP-Abl cell line restored the response to the DHT induction of PSA transcription and also increased the growth response of the LNCaP-Abl cells to the androgen treatment. Changing the expression level of p27/kip1, a known target of miR-221 and miR-222, alone in LNCaP cells affected the DHT-independent cell growth but did not significantly influence the response of PSA transcription to the DHT treatment. In conclusion, our data suggest the involvement of miR-221 and miR-222 in the development or maintenance of the CRPC phenotype.
Conflict of interest statement
The authors declare no conflict of interests.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2703812/bin/nihms97177f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2703812/bin/nihms97177f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2703812/bin/nihms97177f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2703812/bin/nihms97177f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2703812/bin/nihms97177f5.gif)
Similar articles
-
Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.Oncotarget. 2017 Feb 7;8(6):10324-10347. doi: 10.18632/oncotarget.14401. Oncotarget. 2017. PMID: 28055971 Free PMC article.
-
MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.Oncogene. 2014 May 22;33(21):2790-800. doi: 10.1038/onc.2013.230. Epub 2013 Jun 17. Oncogene. 2014. PMID: 23770851 Free PMC article.
-
Androgen regulation of micro-RNAs in prostate cancer.Prostate. 2011 May;71(6):604-14. doi: 10.1002/pros.21276. Epub 2010 Oct 13. Prostate. 2011. PMID: 20945501
-
Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.Prostate. 2008 Jun 1;68(8):839-48. doi: 10.1002/pros.20749. Prostate. 2008. PMID: 18302198 Free PMC article.
-
Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.Cancer Res. 2004 Oct 1;64(19):7156-68. doi: 10.1158/0008-5472.CAN-04-1121. Cancer Res. 2004. PMID: 15466214
Cited by
-
Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review.Cancers (Basel). 2024 Jan 25;16(3):523. doi: 10.3390/cancers16030523. Cancers (Basel). 2024. PMID: 38339274 Free PMC article. Review.
-
Simultaneous subset tracing and miRNA profiling of tumor-derived exosomes via dual-surface-protein orthogonal barcoding.Sci Adv. 2023 Oct 6;9(40):eadi1556. doi: 10.1126/sciadv.adi1556. Epub 2023 Oct 4. Sci Adv. 2023. PMID: 37792944 Free PMC article.
-
Responsive Nucleic Acid-Based Organosilica Nanoparticles.J Am Chem Soc. 2023 Oct 25;145(42):22896-22902. doi: 10.1021/jacs.3c00393. Epub 2023 Sep 21. J Am Chem Soc. 2023. PMID: 37734737 Free PMC article.
-
Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling.Cancer Sci. 2023 Nov;114(11):4252-4269. doi: 10.1111/cas.15948. Epub 2023 Sep 6. Cancer Sci. 2023. PMID: 37671589 Free PMC article.
-
Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms.Cancers (Basel). 2023 Jun 10;15(12):3140. doi: 10.3390/cancers15123140. Cancers (Basel). 2023. PMID: 37370750 Free PMC article. Review.
References
-
- Huggins CB, Hodges CV. Studies on prostatic cancer. 1. The effect of castration, of estrogen and of androgen injections on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1:293–7. - PubMed
-
- Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001;1:34–45. - PubMed
-
- Rana TM. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol. 2007;8:23–36. - PubMed
-
- Glinsky GV. An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway. Cell Cycle. 2008;7:2570–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous